These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 18582147)

  • 1. Improving outcomes of elderly patients with community-acquired pneumonia.
    Gutiérrez F; Masiá M
    Drugs Aging; 2008; 25(7):585-610. PubMed ID: 18582147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elderly patients with community-acquired pneumonia: optimal treatment strategies.
    Thiem U; Heppner HJ; Pientka L
    Drugs Aging; 2011 Jul; 28(7):519-37. PubMed ID: 21721597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited value of routine microbiological diagnostics in patients hospitalized for community-acquired pneumonia.
    Lidman C; Burman LG; Lagergren A; Ortqvist A
    Scand J Infect Dis; 2002; 34(12):873-9. PubMed ID: 12587618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community-acquired pneumonia in the elderly: a practical guide to treatment.
    Lieberman D; Lieberman D
    Drugs Aging; 2000 Aug; 17(2):93-105. PubMed ID: 10984198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Guideline 'Diagnosis and treatment of community-acquired pneumonia' from the Dutch Thoracic Society].
    Aleva RM; Boersma WG;
    Ned Tijdschr Geneeskd; 2005 Nov; 149(45):2501-7. PubMed ID: 16304887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community-acquired pneumonia? A systematic review.
    Oosterheert JJ; Bonten MJ; Hak E; Schneider MM; Hoepelman IM
    J Antimicrob Chemother; 2003 Oct; 52(4):555-63. PubMed ID: 12972448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug treatment of pneumococcal pneumonia in the elderly.
    Neralla S; Meyer KC
    Drugs Aging; 2004; 21(13):851-64. PubMed ID: 15493950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe community-acquired pneumonia in general medical wards: outcomes and impact of initial antibiotic selection.
    Wongsurakiat P; Chitwarakorn N
    BMC Pulm Med; 2019 Oct; 19(1):179. PubMed ID: 31619219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-acquired pneumonia in children: issues in optimizing antibacterial treatment.
    Korppi M
    Paediatr Drugs; 2003; 5(12):821-32. PubMed ID: 14658923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience.
    Ioachimescu OC; Ioachimescu AG; Iannini PB
    Int J Antimicrob Agents; 2004 Nov; 24(5):485-90. PubMed ID: 15519482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of ten day moxifloxacin 400 mg once daily in the treatment of patients with community-acquired pneumonia. Community Acquired Pneumonia Study Group.
    Patel T; Pearl J; Williams J; Haverstock D; Church D
    Respir Med; 2000 Feb; 94(2):97-105. PubMed ID: 10714413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumonia in the elderly (geriatric) population.
    Janssens JP
    Curr Opin Pulm Med; 2005 May; 11(3):226-30. PubMed ID: 15818184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current status of diagnosis and treatment of community-acquired pneumonia in Shanghai revealed by a questionnaire analysis].
    Liu J; Zhang J; Cheng QJ; Xu JF; Jie ZJ; Jiao Y; Huang Y; Qu JM
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Apr; 41(4):288-295. PubMed ID: 29690685
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical characteristics of community-acquired pneumonia due to Moraxella catarrhalis in adults: a retrospective single-centre study.
    Hirai J; Kinjo T; Koga T; Haranaga S; Motonaga E; Fujita J
    BMC Infect Dis; 2020 Nov; 20(1):821. PubMed ID: 33172398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community acquired bacterial pneumonia.
    Anevlavis S; Bouros D
    Expert Opin Pharmacother; 2010 Feb; 11(3):361-74. PubMed ID: 20085502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-acquired pneumonia.
    Cassiere HA; Niederman MS
    Dis Mon; 1998 Nov; 44(11):613-75. PubMed ID: 9858958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 18. Pneumococcal community-acquired pneumonia in 148 hospitalized adult patients.
    Porath A; Schlaeffer F; Pick N; Leinonen M; Lieberman D
    Eur J Clin Microbiol Infect Dis; 1997 Dec; 16(12):863-70. PubMed ID: 9495665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe community-acquired pneumonia as a cause of severe sepsis: data from the PROWESS study.
    Laterre PF; Garber G; Levy H; Wunderink R; Kinasewitz GT; Sollet JP; Maki DG; Bates B; Yan SC; Dhainaut JF;
    Crit Care Med; 2005 May; 33(5):952-61. PubMed ID: 15891319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CURB-65, PSI, and APACHE II to assess mortality risk in patients with severe sepsis and community acquired pneumonia in PROWESS.
    Richards G; Levy H; Laterre PF; Feldman C; Woodward B; Bates BM; Qualy RL
    J Intensive Care Med; 2011; 26(1):34-40. PubMed ID: 21341394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.